Cephalon Says Patent Toss Doesn't Bar Pay-For-Delay Defense
By Matt Fair ( January 23, 2014, 8:55 PM EST) -- Cephalon Inc. told a Pennsylvania federal judge Thursday that it should be allowed to defend a series of pay-for-delay deals it struck with generic-drug competitors over the narcolepsy drug Provigil during a potential trial on antitrust claims brought by several purchaser classes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.